Detalles de la búsqueda
1.
Three- versus six-month adjuvant FOLFOX or CAPOX for high-risk stage II and stage III colon cancer patients: the efficacy results of Hellenic Oncology Research Group (HORG) participation to the International Duration Evaluation of Adjuvant Chemotherapy (IDEA) project.
Ann Oncol
; 30(8): 1304-1310, 2019 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31228203
2.
Dose-dense FEC followed by docetaxel versus docetaxel plus cyclophosphamide as adjuvant chemotherapy in women with HER2-negative, axillary lymph node-positive early breast cancer: a multicenter randomized study by the Hellenic Oncology Research Group (HORG).
Ann Oncol
; 27(10): 1873-8, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27502729
3.
Six versus 12 months of adjuvant trastuzumab in combination with dose-dense chemotherapy for women with HER2-positive breast cancer: a multicenter randomized study by the Hellenic Oncology Research Group (HORG).
Ann Oncol
; 26(7): 1333-40, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25935793
4.
Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Ann Oncol
; 29(Suppl 4): iv51-iv67, 2018 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29846498
5.
Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Ann Oncol
; 29(Suppl 4): iv68-iv78, 2018 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29846513
6.
Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Ann Oncol
; 29(Suppl 4): iv79-iv95, 2018 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30285218
7.
Irinotecan plus gemcitabine vs irinotecan for the second-line treatment of patients with advanced non-small-cell lung cancer pretreated with docetaxel and cisplatin: a multicentre, randomised, phase II study.
Br J Cancer
; 91(3): 482-8, 2004 Aug 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-15238986
Resultados
1 -
7
de 7
1
Próxima >
>>